RT Journal Article
SR Electronic
T1 Inactivation of interleukin-30 in colon cancer stem cells via CRISPR/Cas9 genome editing inhibits their oncogenicity and improves host survival
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e006056
DO 10.1136/jitc-2022-006056
VO 11
IS 3
A1 D'Antonio, Luigi
A1 Fieni, Cristiano
A1 Ciummo, Stefania Livia
A1 Vespa, Simone
A1 Lotti, Lavinia
A1 Sorrentino, Carlo
A1 Di Carlo, Emma
YR 2023
UL http://jitc.bmj.com/content/11/3/e006056.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.